These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 19502783)

  • 1. Altered expression of DACH1 and cyclin D1 in endometrial cancer.
    Nan F; Lü Q; Zhou J; Cheng L; Popov VM; Wei S; Kong B; Pestell RG; Lisanti MP; Jiang J; Wang C
    Cancer Biol Ther; 2009 Aug; 8(16):1534-9. PubMed ID: 19502783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DACH1 inhibits cyclin D1 expression, cellular proliferation and tumor growth of renal cancer cells.
    Chu Q; Han N; Yuan X; Nie X; Wu H; Chen Y; Guo M; Yu S; Wu K
    J Hematol Oncol; 2014 Oct; 7():73. PubMed ID: 25322986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of DNA topoisomerase II-alpha (Ki-S1) immunoexpression in endometrial carcinoma.
    Bildrici K; Tel N; Ozalp SS; Yalcin OT; Yilmaz V
    Eur J Gynaecol Oncol; 2002; 23(6):540-4. PubMed ID: 12556100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of Bcl-2, p53 overexpression, and lymph node metastasis in surgically staged endometrial carcinoma.
    Ohkouchi T; Sakuragi N; Watari H; Nomura E; Todo Y; Yamada H; Fujimoto S
    Am J Obstet Gynecol; 2002 Aug; 187(2):353-9. PubMed ID: 12193924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prognostic significance of estrogen and progesterone receptors in grade I and II endometrioid endometrial adenocarcinoma: hormone receptors in risk stratification.
    Guan J; Xie L; Luo X; Yang B; Zhang H; Zhu Q; Chen X
    J Gynecol Oncol; 2019 Jan; 30(1):e13. PubMed ID: 30479097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DACH1 is a cell fate determination factor that inhibits cyclin D1 and breast tumor growth.
    Wu K; Li A; Rao M; Liu M; Dailey V; Yang Y; Di Vizio D; Wang C; Lisanti MP; Sauter G; Russell RG; Cvekl A; Pestell RG
    Mol Cell Biol; 2006 Oct; 26(19):7116-29. PubMed ID: 16980615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multivariate independent prognostic factors in endometrial carcinoma: a clinicopathologic study in 181 patients: 10 years experience at the Department of Obstetrics and Gynecology of the Mainz University.
    Steiner E; Eicher O; Sagemüller J; Schmidt M; Pilch H; Tanner B; Hengstler JG; Hofmann M; Knapstein PG
    Int J Gynecol Cancer; 2003; 13(2):197-203. PubMed ID: 12657124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pelvic lymph node count is an important prognostic variable for FIGO stage I and II endometrial carcinoma with high-risk histology.
    Lutman CV; Havrilesky LJ; Cragun JM; Secord AA; Calingaert B; Berchuck A; Clarke-Pearson DL; Soper JT
    Gynecol Oncol; 2006 Jul; 102(1):92-7. PubMed ID: 16406063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parametrial spread is a prognostic factor in endometrial carcinoma.
    Sato R; Jobo T; Kuramoto H
    Eur J Gynaecol Oncol; 2003; 24(3-4):241-5. PubMed ID: 12807232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hormone receptor loss in endometrial carcinoma curettage predicts lymph node metastasis and poor outcome in prospective multicentre trial.
    Trovik J; Wik E; Werner HM; Krakstad C; Helland H; Vandenput I; Njolstad TS; Stefansson IM; Marcickiewicz J; Tingulstad S; Staff AC; ; Amant F; Akslen LA; Salvesen HB
    Eur J Cancer; 2013 Nov; 49(16):3431-41. PubMed ID: 23932335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclin D1 expression in endometrioid-type endometrial adenocarcinoma is correlated with histological grade and proliferative activity, but not with prognosis.
    Nishimura Y; Watanabe J; Jobo T; Kato N; Fujisawa T; Kamata Y; Kuramoto H
    Anticancer Res; 2004; 24(4):2185-91. PubMed ID: 15330159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer.
    Watari H; Todo Y; Takeda M; Ebina Y; Yamamoto R; Sakuragi N
    Gynecol Oncol; 2005 Mar; 96(3):651-7. PubMed ID: 15721407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Analysis of the status of DACH1 gene promoter methylation in endometrial carcinoma and its clinical significance].
    Deng XC; Li SR; Zhang Q; Zhou CJ; Yang QF; Jiang J; Kong BH
    Zhonghua Fu Chan Ke Za Zhi; 2012 Apr; 47(4):263-7. PubMed ID: 22781112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of MMSET in endometrial cancer: a clinicopathologic study.
    Xiao M; Yang S; Chen J; Ning X; Guo L; Huang K; Sui L
    J Surg Oncol; 2013 Mar; 107(4):428-32. PubMed ID: 22886632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DACH1 mutation frequency in endometrial cancer is associated with high tumor mutation burden.
    Riggs MJ; Lin N; Wang C; Piecoro DW; Miller RW; Hampton OA; Rao M; Ueland FR; Kolesar JM
    PLoS One; 2020; 15(12):e0244558. PubMed ID: 33378353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclin D1 is significantly associated with stage of tumor and predicts poor survival in endometrial carcinoma patients.
    Khabaz MN; Abdelrahman AS; Butt NS; Al-Maghrabi B; Al-Maghrabi J
    Ann Diagn Pathol; 2017 Oct; 30():47-51. PubMed ID: 28965628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term survival in patients with para-aortic lymph node metastasis with systematic retroperitoneal lymphadenectomy followed by adjuvant chemotherapy in endometrial carcinoma.
    Hiura M; Nogawa T; Matsumoto T; Yokoyama T; Shiroyama Y; Wroblewski J
    Int J Gynecol Cancer; 2010 Aug; 20(6):1000-5. PubMed ID: 20683408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathological significance of fragile histidine triad transcription protein expression in endometrial carcinomas.
    Segawa T; Sasagawa T; Saijoh K; Inoue M
    Clin Cancer Res; 2000 Jun; 6(6):2341-8. PubMed ID: 10873085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of body mass index on clinicopathologic features, surgical morbidity and outcome in patients with endometrial cancer.
    Akbayır O; Corbacıoglu Esmer A; Numanoglu C; Cılesız Goksedef BP; Akca A; Bakır LV; Kuru O
    Arch Gynecol Obstet; 2012 Nov; 286(5):1269-76. PubMed ID: 22729137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DACH1 inhibits lung adenocarcinoma invasion and tumor growth by repressing CXCL5 signaling.
    Han N; Yuan X; Wu H; Xu H; Chu Q; Guo M; Yu S; Chen Y; Wu K
    Oncotarget; 2015 Mar; 6(8):5877-88. PubMed ID: 25788272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.